he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源位址
上一页:早期的癫痫都有哪些病症
- 2022-05-04霍奇金遗传病的病因 如何治疗霍奇金遗传病
- 2022-04-282013年国际抗癫痫联合会抗癫痫制剂使用指南
- 2019-04-18保定哪家羊癫疯医院好
- 张海澄,北京大学人民医院:心脏病发作后的该如何保障?
- 癫痫患者为什么要检查脑电图?
- 第二届微创、超声介入学科发展及临床应用研讨会
- 他们在对抗子宫腺肌病的路上走了太多弯路!
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 异常勃起需要尽快治疗
- 尿液出现这8种颜色要小心,可能是疾病的信号!
- JAAD:紫外线光疗会增加湿疹患者皮肤癌的发病率吗?
- 癫痫猝死:凶手是谁?
- 奇怪的精神分裂症行为令人困惑 手术可以帮助患者恢复正常
- 扬子江药业评价信息:同日两品种获批上市!今年,共有86个品种的评价
- 男人手术后真的会强吗?
- 三庚酸酯可治疗1型转运体缺陷综合征
- Rheumatology:甘氨酸通过SAM介导的GPX4类风湿性关节炎启动子甲基化铁浓度变化研究
- 如何治疗 钙化
- 宫颈糜烂是严重的妇科疾病吗?
- 如何治疗附睾囊肿?医生介绍了治疗方法!
- Medpage Today:不同类型的抗癫痫药物更有利
- 脑梗死的症状是什么有这些前兆要谨慎
- 县域健康正骨瘦脸?不可能,别想了!
- 谁说生不出娃娃 是女人的错!?
- 吃什么补肾效果比较好?
- AJH:青少年双向障碍与无贫血缺铁和疲劳症状的关系
- 儿童癫痫的早期症状 癫痫的原因
- 李敖病逝!面对医疗展示勇士的姿态
- 每个女人都是江湖……
- 移位性骶骨骨折手术后10年随访功能恢复不乐观
- 癫痫病是什么病 癫痫如何病患比较好
- 什么是癫痫 病症如何进行心理调节
- 癫痫病的健身治疗
- 病患癫痫病哪家医院好
- 外科手术真的能根治癫痫吗?4大外科化疗方法,看完就清楚了!
- 怎么样治好癫痫病才最直接
- 卫材在俄罗斯上架癫痫新药Fycompa
- 抗癫痫药性可以延缓衰老
- 了解婴儿脑瘤的病因 具体有哪些
- 癫痫病的早期病症 患有癫痫万不可吃它(2)
- “药不能停”!擅自中毒者,癫痫频繁发作
- 奥林匹克运动会中国代表团频发癫痫症 奥林匹克运动会中国代表团为何频发癫痫症
- 引起癫痫病的性疾病有哪些